Assessment of Heterogeneity of Cytochrome P450 Activity in Cancer-Cell Population by Cytometry of Reaction Rate Constant is Robust to Variation in Substrate Concentration
M. Bleker de Oliveira, V. Koshkin, C. G. R. Perry, S. N. Krylov
Abstract
Enzymes of the cytochrome P450 (CYP) family catalyze the metabolism of chemotherapeutic agents and are among the key players in primary and acquired chemoresistance of cancer. The activity of CYP is heterogeneous in tumor tissues, and the quantitative characteristics of this heterogeneity can be used to predict chemoresistance. Cytometry of reaction rate constant (CRRC) is a kinetic approach to assess cell population heterogeneity by measuring rates of processes at the single-cell level via time-lapse imaging. CRRC was shown to be an accurate and robust method for assessing the heterogeneity of drug-extrusion activity catalyzed by ABC transporters, which are also key players in cancer chemoresistance. We hypothesized that CRRC is also a reliable method for assessing the heterogeneity of CYP activity. Here, we evaluated the robustness of assessing the heterogeneity of CYP activity by CRRC with respect to controlled variation in the concentration of a CYP substrate by comparing CRRC with non-kinetic approaches. We found that changing the substrate concentration by 20% resulted only in minimal changes in the position, width, and asymmetry of the peak in the CRRC histogram, while these parameters varied greatly in the non-kinetic histograms. Moreover, the Kolmogorov-Smirnov statistical test showed that the distribution of the cell population in CRRC histograms was not significantly different; the result was opposite for non-kinetic histograms. In conclusion, we were able to demonstrate the robustness of CRRC with respect to changes in substrate concentration when evaluating CYP activity at the single-cell level.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sequential Measurements of Catalytic Activities of Multi-Drug-Resistance Transporters and Cytochrome P450 Enzymes by Cytometry of Reaction Rate Constant
V. Koshkin, M. Bleker de Oliveria, … S. N. Krylov·bioRxiv·Oct 15, 2020
- Pharmacokinetic Acceleration via CYP3A4 Hyperactivation as a Clinically Actionable Mechanism of Targeted Therapy Resistance in NSCLC
Pragya Kumar, Menkara Henry, … Andriy Marusyk·bioRxiv·May 20, 2026
- Tumor Microenvironment Alters Chemoresistance of Hepatocellular Carcinoma Through CYP3A4 Metabolic Activity
A. Ozkan, D. L. Stolley, … M. N. Rylander·bioRxiv·Jan 23, 2021
- Development and characterization of pFluor50, a fluorogenic-based kinetic assay system for high-throughput inhibition screening and characterization of time-dependent inhibition and inhibition type for six human CYPs
P. Shriwas, A. Revnew, … C. A. McElroy·bioRxiv·Aug 15, 2023
- Cirrhosis and Inflammation Regulates CYP3A4 Mediated Chemoresistance in Vascularized Hepatocellular Carcinoma-on-a-chip
A. Ozkan, D. L. Stolley, … M. N. Rylander·bioRxiv·May 4, 2022
- Collateral Responses to Classical Cytotoxic Chemotherapies are Heterogeneous and Sensitivities are Sparse
S. Dalin, D. A. Lauffenburger, M. Hemann·bioRxiv·Apr 15, 2021